{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:36:16Z","timestamp":1790858176015,"version":"4.1.0"},"reference-count":63,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003448","name":"EU and Greek national funds","doi-asserted-by":"publisher","award":["T2EDK-03044"],"award-info":[{"award-number":["T2EDK-03044"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of liver-related morbidity and mortality. Although the invasive liver biopsy remains the golden standard for MASLD diagnosis, Magnetic Resonance Imaging-derived Proton Density Fat Fraction (MRI-PDFF) is an accurate, non-invasive method for the assessment of treatment response. This study aimed at developing a Polygenic Risk Score (PRS) to improve MRI-PDFF prediction using UK Biobank data to assess an individual\u2019s genetic liability to MASLD. Methods: We iteratively sequestered 10% of MRI-PDFF samples as a validation set and split the rest of each dataset into base and target partitions, containing GWAS summary statistics and raw genotype data, respectively. PRSice2 was deployed to derive PRS candidates. Based on the frequency of SNP appearances along the PRS candidates, we generated different SNP sets according to variable frequency cutoffs. By applying the PRSs to the validation set, we identified the optimal SNP set, which was then applied to a Greek nonalcoholic fatty liver disease (NAFLD) study. Results: Data from 3553 UK Biobank participants yielded 49 different SNP sets. After calculating the PRS on the validation set for every SNP set, an optimal PRS with 75 SNPs was selected (incremental R2 = 0.025, p-value = 0.00145). Interestingly, 43 SNPs were successfully mapped to MASLD-related known genes. The selected PRS could predict traits, like LDL cholesterol and diastolic blood pressure in the UK Biobank, as also disease outcome in the Greek NAFLD study. Conclusions: Our findings provide strong evidence that PRS is a powerful prediction model for MASLD, while it can also be applied on populations of different ethnicity.<\/jats:p>","DOI":"10.3390\/genes16010033","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:37:19Z","timestamp":1735648639000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of a Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease Prediction in UK Biobank"],"prefix":"10.3390","volume":"16","author":[{"given":"Panagiota","family":"Giardoglou","sequence":"first","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3803-9168","authenticated-orcid":false,"given":"Ioanna","family":"Gavra","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7303-5664","authenticated-orcid":false,"given":"Athina I.","family":"Amanatidou","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-7491","authenticated-orcid":false,"given":"Ioanna Panagiota","family":"Kalafati","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"},{"name":"Department of Nutrition and Dietetics, School of Physical Education, Sport Science and Dietetics, University of Thessaly, 42132 Trikala, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8813-5075","authenticated-orcid":false,"given":"Panagiotis","family":"Symianakis","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9665-0829","authenticated-orcid":false,"given":"Maria","family":"Kafyra","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4199-0333","authenticated-orcid":false,"given":"Panagiotis","family":"Moulos","sequence":"additional","affiliation":[{"name":"Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center \u2018Alexander Fleming\u2019, 16672 Vari, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-6221","authenticated-orcid":false,"given":"George V.","family":"Dedoussis","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 17671 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","article-title":"NAFLD\u2014Sounding the Alarm on a Silent Epidemic","volume":"17","author":"Lazarus","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and Increased Risk of Cardiovascular Disease: Clinical Associations, Pathophysiological Mechanisms and Pharmacological Implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The Complex Link between NAFLD and Type 2 Diabetes Mellitus\u2014Mechanisms and Treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Guo, Z., Wu, Q., Xie, P., Wang, J., and Lv, W. (2024). Immunomodulation in Non-Alcoholic Fatty Liver Disease: Exploring Mechanisms and Applications. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1336493"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41514-023-00127-z","article-title":"Machine Learning Prediction of Hepatic Steatosis Using Body Composition Parameters: A UK Biobank Study","volume":"10","author":"Boncan","year":"2024","journal-title":"npj Aging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.4254\/wjh.v13.i11.1494","article-title":"Promising Diagnostic Biomarkers of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: From Clinical Proteomics to Microbiome","volume":"13","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yin, X., Guo, X., Liu, Z., and Wang, J. (2023). Advances in Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032844"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of NAFLD and NASH","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Piazzolla, V.A., and Mangia, A. (2020). Noninvasive Diagnosis of NAFLD and NASH. Cells, 9.","DOI":"10.3390\/cells9041005"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.31121","article-title":"Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH","volume":"72","author":"Loomba","year":"2020","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive Evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Meroni, M., Longo, M., Tria, G., and Dongiovanni, P. (2021). Genetics Is of the Essence to Face Nafld. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101359"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Riazi, K., Swain, M.G., Congly, S.E., Kaplan, G.G., and Shaheen, A.A. (2022). Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients, 14.","DOI":"10.3390\/nu14214556"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores","volume":"20","author":"Tavaglione","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00394-018-1675-4","article-title":"Fish Intake Interacts with TM6SF2 Gene Variant to Affect NAFLD Risk: Results of a Case\u2013Control Study","volume":"58","author":"Kalafati","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_19","unstructured":"The UK Biobank (2019, December 17). Basis of Your Participation. Available online: https:\/\/www.ukbiobank.ac.uk\/explore-your-participation\/basis-of-your-participation."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of Patients with NAFLD Meet MASLD Criteria and Natural History Is Therefore Identical","volume":"80","author":"Vessby","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kafyra, M., Kalafati, I.P., Dimitriou, M., Grigoriou, E., Kokkinos, A., Rallidis, L., Kolovou, G., Trovas, G., Marouli, E., and Deloukas, P. (2023). Robust Bioinformatics Approaches Result in the First Polygenic Risk Score for BMI in Greek Adults. J. Pers. Med., 13.","DOI":"10.3390\/jpm13020327"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"giz082","DOI":"10.1093\/gigascience\/giz082","article-title":"PRSice-2: Polygenic Risk Score Software for Biobank-Scale Data","volume":"8","author":"Choi","year":"2019","journal-title":"Gigascience"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the Caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"Profiler: A Web Server for Functional Enrichment Analysis and Conversions of Gene Lists (2019 Update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_26","unstructured":"(2020, June 20). DisGENEnet. Available online: https:\/\/www.disgenet.org\/."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A Population-Based Study on the Prevalence of NASH Using Scores Validated against Liver Histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). Ggplot2: Elegant Graphics for Data Analysis, Springer.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/dmrr.666","article-title":"Alanine Aminotransferase as a Marker Ofnon-Alcoholic Fatty Liver Disease in Relation to Type2 Diabetes Mellitus and Cardiovascular Disease","volume":"22","author":"Schindhelm","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of Liver Diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tips.2020.12.001","article-title":"Triglycerides in Nafld: Guilty Until Proven Innocent","volume":"42","author":"Semova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.athplu.2023.08.001","article-title":"High-Density Lipoproteins and Non-Alcoholic Fatty Liver Disease","volume":"53","author":"Hoekstra","year":"2023","journal-title":"Atheroscler. Plus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/21655979.2021.1933302","article-title":"The Association between Hypertension and Nonalcoholic Fatty Liver Disease (NAFLD): Literature Evidence and Systems Biology Analysis","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"G:Profiler-Interoperable Web Service for Functional Enrichment Analysis and Gene Identifier Mapping (2023 Update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","article-title":"The DisGeNET Cytoscape App: Exploring and Visualizing Disease Genomics Data","volume":"19","author":"Sanz","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: Tool for the Unification of Biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Schwarzerova, J., Hurta, M., Barton, V., Lexa, M., Walther, D., Provaznik, V., and Weckwerth, W. (2024). A Perspective on Genetic and Polygenic Risk Scores\u2014Advances and Limitations and Overview of Associated Tools. Brief. Bioinform., 25.","DOI":"10.1093\/bib\/bbae240"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamainternmed.2022.3171","article-title":"Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review","volume":"182","author":"Groenendyk","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bju.15752","article-title":"The Current State of Genetic Risk Models for the Development of Kidney Cancer: A Review and Validation","volume":"130","author":"Harrison","year":"2022","journal-title":"BJU Int."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Li, C., Hou, Y., Ou, R., Wei, Q., Zhang, L., Liu, K., Lin, J., Chen, X., Song, W., and Zhao, B. (2024). GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson\u2019s Disease. J. Gerontol. A Biol. Sci. Med. Sci., 6.","DOI":"10.1093\/gerona\/glae155"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Clifton, L., Collister, J.A., Liu, X., Littlejohns, T.J., and Hunter, D.J. (2022). Assessing Agreement between Different Polygenic Risk Scores in the UK Biobank. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-17012-6"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Burrows, K., Fuller, H., Speliotes, E.K., Abeysekera, K.W.M., Thorne, J.L., Lewis, S.J., Zulyniak, M.A., and Moore, J.B. (2023). Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study. Nutrients, 15.","DOI":"10.3390\/nu15061442"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1053\/j.gastro.2020.06.014","article-title":"Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1","volume":"159","author":"Innes","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1194\/jlr.M048777","article-title":"The Rs738409 (I148M) Variant of the PNPLA3 Gene and Cirrhosis: A Meta-Analysis","volume":"56","author":"Shen","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bianco, C., Jamialahmadi, O., Pelusi, S., Baselli, G., Dongiovanni, P., Zanoni, I., Santoro, L., Maier, S., Liguori, A., and Meroni, M. (2021). Non-Invasive Stratification of Hepatocellular Carcinoma Risk in Non-Alcoholic Fatty Liver Using Polygenic Risk Scores, European Association for the Study of the Liver.","DOI":"10.1016\/j.jhep.2020.11.024"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lambert, S.A., Wingfield, B., Gibson, J.T., Gil, L., Yvon, F., Saverimuttu, S., Tinsley, E., and Lewis, E. (2024). The Polygenic Score Catalog: New Functionality and Tools to Enable FAIR Research Main Text Expanding the PGS Catalog Data Content and Evolving the User. medRxiv.","DOI":"10.1101\/2024.05.29.24307783"},{"key":"ref_47","first-page":"e0431","article-title":"A Polygenic Risk Score for Alcohol-Associated Cirrhosis among Heavy Drinkers with European Ancestry","volume":"8","author":"Whitfield","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kanoni, S., Graham, S.E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S.L., Bhatti, K.F., Vedantam, S., and Winkler, T.W. (2022). Implicating Genes, Pleiotropy, and Sexual Dimorphism at Blood Lipid Loci through Multi-Ancestry Meta-Analysis. Genome Biol., 23.","DOI":"10.1186\/s13059-022-02837-1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41698-023-00377-w","article-title":"Potential Utility of Risk Stratification for Multicancer Screening with Liquid Biopsy Tests","volume":"7","author":"Kim","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41398-020-00865-8","article-title":"Using Polygenic Scores for Identifying Individuals at Increased Risk of Substance Use Disorders in Clinical and Population Samples","volume":"10","author":"Barr","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Petrican, R., Paine, A.L., Escott-Price, V., and Shelton, K.H. (2023). Overlapping Brain Correlates of Superior Cognition among Children at Genetic Risk for Alzheimer\u2019s Disease and\/or Major Depressive Disorder. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-28057-6"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of Novel Risk Loci, Causal Insights, and Heritable Risk for Parkinson\u2019s Disease: A Meta-Analysis of Genome-Wide Association Studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal Relationship of Hepatic Fat with Liver Damage and Insulin Resistance in Nonalcoholic Fatty Liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 Gene in Liver Diseases","volume":"65","author":"Romeo","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Namjou, B., Lingren, T., Huang, Y., Parameswaran, S., Cobb, B.L., Stanaway, I.B., Connolly, J.J., Mentch, F.D., Benoit, B., and Niu, X. (2019). GWAS and Enrichment Analyses of Non-Alcoholic Fatty Liver Disease Identify New Trait-Associated Genes and Pathways across EMERGE Network. BMC Med., 17.","DOI":"10.1186\/s12916-019-1364-z"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1038\/s41467-021-25468-9","article-title":"A Human Liver Cell-Based System Modeling a Clinical Prognostic Liver Signature for Therapeutic Discovery","volume":"12","author":"Crouchet","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_58","first-page":"4908","article-title":"CREB5 Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma","volume":"11","author":"Wu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2007.06.006","article-title":"RNA-Binding Protein RBMS3 Is Expressed in Activated Hepatic Stellate Cells and Liver Fibrosis and Increases Expression of Transcription Factor Prx1","volume":"371","author":"Fritz","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of Multi-Omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease","volume":"6","author":"Kurt","year":"2018","journal-title":"Cell Syst."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Riordan, J.D., Keng, V.W., Tschida, B.R., Scheetz, T.E., Bell, J.B., Podetz-pedersen, K.M., Moser, C.D., Copeland, N.G., Jenkins, N.A., and Roberts, L.R. (2013). Identification of Rtl1, a Retrotransposon-Derived Imprinted Gene, as a Novel Driver of Hepatocarcinogenesis. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003441"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Soto, A., Spongberg, C., Martinino, A., and Giovinazzo, F. (2024). Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020397"},{"key":"ref_63","first-page":"100780","article-title":"Prognostic Utility of Fibrosis-4 Index for Risk of Subsequent Liver and Cardiovascular Events, and All-Cause Mortality in Individuals with Obesity and\/or Type 2 Diabetes: A Longitudinal Cohort Study","volume":"36","author":"Anstee","year":"2024","journal-title":"Lancet Reg. Health-Eur."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/1\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:06Z","timestamp":1760115306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/1\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["genes16010033"],"URL":"https:\/\/doi.org\/10.3390\/genes16010033","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]}}}